Status:
COMPLETED
Intraoperative Biodegradable Stent Placement to Reduce Complications After Pancreatoduodenectomy
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Fistula Pancreatic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this prospective, randomized, blinded clinical superiority trial is to establish intraoperative placement of biodegradable stents in the pancreatojejunostomy as a safe, effective, and feasi...
Eligibility Criteria
Inclusion
- Patients undergoing a pancreatoduodenectomy
- Patients aged 18 or above
- Patients who have given an informed consent
Exclusion
- Patients who do not or cannot give an informed consent.
- Patients with at a high risk or with previous history of multiple thrombo-embolic diseases or bleeding disorders.
- Patients undergoing active immunosuppressive therapy.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06205693
Start Date
October 1 2023
End Date
May 1 2025
Last Update
June 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Capitol, Denmark, 2100